Recombinant rotavirus expressing the glycosylated S1 protein of SARS-CoV-2
Asha A. Philip(Indiana University Bloomington), John T. Patton(The Ohio State University)
Cited by 6
Related Papers
The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease
|Oncotarget|2014|28
Rotavirus as an Expression Platform of the SARS-CoV-2 Spike Protein
|bioRxiv (Cold Spring Harbor Laboratory)|2021|9
Generation of Recombinant Rotavirus Expressing NSP3-UnaG Fusion Protein by a Simplified Reverse Genetics System
|bioRxiv (Cold Spring Harbor Laboratory)|2019|8
Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1
Expression of Separate Foreign Proteins from the Rotavirus NSP3 Genome Segment Using a Translational 2A Stop-Restart Element
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0